首页> 外文期刊>Transfusion: The Journal of the American Association of Blood Banks >The efficacy of the ultraviolet C pathogen inactivation system in the reduction of Babesia divergens in pooled buffy coat platelets
【24h】

The efficacy of the ultraviolet C pathogen inactivation system in the reduction of Babesia divergens in pooled buffy coat platelets

机译:紫外线C病原体灭活系统在减少血沉棕黄层血小板聚集中的巴氏杆菌多样性中的功效

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

BACKGROUND: Babesia spp. is an intraerythrocytic parasite that causes human babesiosis and its transmission by transfusion has been extensively demonstrated. The aim of this study was to ascertain the efficacy of an ultraviolet C (UVC)-based pathogen inactivation system in the reduction of Babesia divergens infected platelet (PLT) concentrates and to determine the parasite's ability to survive in PLT concentrates stored under blood bank conditions. STUDY DESIGN AND METHODS: This study was conducted using in vitro cultures of B. divergens. The detection limit of the culture assay was established and, subsequently, 15 buffy coat-derived PLT concentrates (BC-PCs) were inoculated with 107 B. divergens infected red blood cells. Infected BC-PCs were irradiated with 0.2 J/cm2 UVC light using the THERAFLEX UV-Platelets method (Macopharma). Viability and parasite growth were evaluated before and after inactivation. Culture growth kinetics were monitored by DNA incorporation of [3H]thymidine. The ability of B. divergens to survive in PLT concentrates was also analyzed. RESULTS: The limit of detection in cultures was established at 0.1 × 10-6% parasites. The THERAFLEX UV-Platelets system inactivated B. divergens to below the limit of detection in 12 of 15 BC-PCs (log reduction, >6.0) and to the limit of detection (log reduction, 5.0) in three of 15. It was also demonstrated that B. divergens remains viable in BC-PCs stored up to 7 days. CONCLUSION: Since B. divergens can survive in PLT concentrates and given the performance of UVC, this system could be considered as an alternative to prevent B. divergens and other Babesia species from being transmitted through PLT transfusions.
机译:背景:巴贝虫属。是引起人类杆状杆菌病的红细胞内寄生虫,其通过输血传播已得到广泛证明。这项研究的目的是确定基于紫外线C(UVC)的病原体灭活系统在减少巴氏杆菌多样性原感染的血小板(PLT)浓缩物中的功效,并确定寄生虫在血库条件下储存的PLT浓缩物中的生存能力。 。研究设计和方法:本研究是利用B. divergens的体外培养进行的。确定了培养分析的检测极限,随后,用107株发芽曲霉感染的红细胞接种了15株来自血沉棕黄层的PLT浓缩物(BC-PCs)。使用THERAFLEX UV-Platelets方法(Macopharma)用0.2 J / cm2 UVC光照射感染的BC-PC。灭活前后评估生存力和寄生虫生长。通过[3 H]胸苷的DNA掺入监测培养物的生长动力学。还分析了B. divergens在PLT浓缩物中存活的能力。结果:培养物中的检出限确定为0.1×10-6%的寄生虫。 THERAFLEX UV-Platelets系统灭活了B. divergens,使其在15台BC-PC中有12台的检出限以下(对数降低,> 6.0),在15台中的三台中的检出限(对数降低,5.0)。证明了B. divergens在BC-PCs中可以存活7天。结论:由于分枝杆菌可以在PLT浓缩物中存活,并且考虑到UVC的性能,该系统可以被认为是防止分枝杆菌和其他巴比斯虫通过PLT输血传播的替代方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号